Redsense Medical AB (publ) (XSAT:REDS)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.930
-0.140 (-3.44%)
At close: Aug 6, 2026

Redsense Medical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
29.1226.832.6325.5617.7916.9
Revenue Growth
-16.37%-17.85%27.66%43.66%5.26%-1.46%
Gross Profit
18.9215.5621.9313.212.310.96
Operating Income
-3.13-7.370.21-5.04-10.21-11.99
Net Income
-2.9-7.170.34-4.51-8.76-7.97
Earnings Per Share
-1.36-0.440.02-0.32-0.62-0.57
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.747.3615.366.9710.5826.95
Total Debt
000002.57
Net Cash (Debt)
9.747.3615.366.9710.5824.38
Net Cash Growth
-39.18%-52.10%120.44%-34.16%-56.60%-62.51%
Net Cash Per Share
4.570.450.900.490.751.74

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.22-5.2-8.23-5.05-9.78-12.22
Capital Expenditures
-0.24-0.03-0.02-0.05-0.050.36
Free Cash Flow
-3.46-5.23-8.25-5.1-9.83-11.86
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
64.95%58.06%67.22%51.64%69.15%64.82%
Operating Margin
-10.76%-27.48%0.64%-19.71%-57.38%-70.95%
Pretax Margin
-9.96%-26.76%1.05%-17.66%-49.23%-47.17%
Profit Margin
-9.96%-26.76%1.05%-17.66%-49.23%-47.17%
FCF Margin
-11.89%-19.51%-25.27%-19.97%-55.26%-70.18%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--355.00---
Forward PE
-284.24284.24284.24284.24284.24
PS Ratio
2.252.173.064.187.4820.44